Nls Pharmaceutics Ag Stock Price on December 3, 2024
| NLSPW Stock | USD 0.01 0.01 83.33% |
If you're considering investing in NLS Stock, it is important to understand the factors that can impact its price. As of today, the current price of NLS Pharmaceutics stands at 0.01, as last reported on the 22nd of December, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. NLS Pharmaceutics is out of control given 3 months investment horizon. NLS Pharmaceutics has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of standard deviation over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 4.78% are justified by taking the suggested risk. Use NLS Pharmaceutics Risk Adjusted Performance of 0.1004, mean deviation of 22.71, and Market Risk Adjusted Performance of (1.17) to evaluate company specific risk that cannot be diversified away.
At this time, NLS Pharmaceutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 3.3 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 35.5 M in 2024. . Price Earnings To Growth Ratio is likely to climb to 1.25 in 2024, whereas Price Earnings Ratio is likely to drop (77.46) in 2024. NLS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NLS |
Sharpe Ratio = 0.1384
| Best Portfolio | Best Equity | NLSPW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 34.5 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.78 actual daily | 95 95% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average NLS Pharmaceutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NLS Pharmaceutics by adding it to a well-diversified portfolio.
Book Value (9.40) | Shares Float 734.8 K | Market Capitalization 37.8 M | Shares Short Prior Month 24.1 K | Shares Short 18 K |
Related Headline
Fate Therapeutics Headline on 3rd of December 2024
Fate Therapeutics Reports New Employee Inducement Award Unde... by gurufocus.com
SAN DIEGO, Dec. 03, 2024 -- Fate Therapeutics, Inc. , a clinical-stage biopharmaceutical company dedicated to bringing a first-in-clas
NLS Pharmaceutics Valuation on December 3, 2024
It is possible to determine the worth of NLS Pharmaceutics on a given historical date. On December 3, 2024 NLS was worth 0.008 at the beginning of the trading date compared to the closed value of 0.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NLS Pharmaceutics stock. Still, in general, we apply an absolute valuation method to find NLS Pharmaceutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NLS Pharmaceutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NLS Pharmaceutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.01 | 0.01 | 0.01 | 0.01 | 16,700 | |
12/03/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 9,900 |
| 0.02 | 0.01 | 0.01 | 0.01 | 313,900 |
| Backtest NLS Pharmaceutics | | | NLS Pharmaceutics History | | | NLS Pharmaceutics Valuation | Previous | Next |
NLS Pharmaceutics Trading Date Momentum on December 3, 2024
| On December 04 2024 NLS Pharmaceutics AG was traded for 0.01 at the closing time. The highest daily price throughout the period was 0.01 and the lowest price was 0.01 . The daily volume was 313.9 K. The net trading volume on 12/04/2024 added to the next day price increase. The trading delta at closing time to closing price of the next trading day was 30.00% . The trading delta at closing time to current closing price is 20.00% . |
NLS Pharmaceutics Fundamentals Correlations and Trends
By evaluating NLS Pharmaceutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NLS Pharmaceutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NLS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NLS Pharmaceutics Stock history
NLS Pharmaceutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NLS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NLS Pharmaceutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NLS Pharmaceutics stock prices may prove useful in developing a viable investing in NLS Pharmaceutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.2 M | 40.1 M | |
| Net Loss | -3.3 M | -3.5 M |
NLS Pharmaceutics Stock Technical Analysis
NLS Pharmaceutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NLS Pharmaceutics Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
NLS Pharmaceutics AG cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NLS Pharmaceutics December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how NLS Pharmaceutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NLS Pharmaceutics shares will generate the highest return on investment. By undertsting and applying NLS Pharmaceutics stock market strength indicators, traders can identify NLS Pharmaceutics AG entry and exit signals to maximize returns
NLS Pharmaceutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NLS Pharmaceutics' price direction in advance. Along with the technical and fundamental analysis of NLS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NLS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1004 | |||
| Jensen Alpha | 4.05 | |||
| Total Risk Alpha | 3.0 | |||
| Sortino Ratio | 0.1425 | |||
| Treynor Ratio | (1.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.